CGRP Antibodies

Santa Cruz Biotechnology features a diverse variety of CGRP Antibodies for understanding Calcitonin Gene-Related Peptide (CGRP) in various physiological processes. CGRP Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CGRP is a neuropeptide that plays a crucial role in pain transmission and vasodilation, making it a significant target in studies related to migraine and cardiovascular health. Research has shown CGRP's involvement in inflammatory responses, highlighting its significance in various pathological conditions. Scientists worldwide are exploring CGRP's mechanisms of action to develop new therapeutic approaches. Understanding CGRP's function can provide insights into potential therapeutic strategies for managing pain and other related disorders. Ongoing studies continue to reveal new aspects of CGRP's role in neurological and cardiovascular systems. CGRP research using Santa Cruz Biotechnology monoclonal antibodies contributes to advancing therapeutic solutions for pain management and related medical conditions.